Intriguingly, mutation of either the distal 5′ or 3′ endogenous HREs completely abolished HIF binding to the proximal EPO promoter HREs as well as to the 3′ HRE in neuroblastoma cells [77]. The gene discussed is EPO; the disease is neuroblastoma.